Get the Stockscreener App
0.5488
0.80%
-0.0044
Nuwellis Inc stock is traded at $0.5488, with a volume of 107.03K.
It is down -0.80% in the last 24 hours and down -32.66% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$0.5532
Open:
$0.5661
24h Volume:
107.03K
Relative Volume:
0.70
Market Cap:
$1.74M
Revenue:
$8.77M
Net Income/Loss:
$-19.05M
P/E Ratio:
-0.000245
EPS:
-2243.7675
Net Cash Flow:
$-11.60M
1W Performance:
-20.35%
1M Performance:
-32.66%
6M Performance:
-98.68%
1Y Performance:
-99.54%
1-Day Range:
$0.53
$0.5879
1-Week Range:
$0.4444
$0.7076
52-Week Range:
$0.4444
$172.90
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
0.5488 | 1.74M | 8.77M | -19.05M | -11.60M | -2,243.77 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
uniQure shares plunge 37% after new trial data shows reduced benefit for Huntington's drug AMT-130 - Pluang
Warrant cap keeps Nuwellis (NUWE) investor under 5% ownership - Stock Titan
Nuwellis adds EHR connectivity to Aquadex platform - scanx.trade
Nuwellis Q2FY26 Results: Gross margin expands to 76%, cash runway extends - scanx.trade
Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins - marketscreener.com
Cash could last into Q3 2027 after Nuwellis shifted production to an outside manufacturer - Stock Titan
Nuwellis, Inc. Announces First Quarter 2026 F - moomoo.com
Nuwellis, Inc. SEC Filing (Aug 27, 2026) - Stock Titan
NUWE Stock Slides As Nuwellis Strikes New Pediatric Deals - timothysykes.com
Nuwellis posts updated investor presentation highlighting Aquadex growth, 20% H1 revenue rise - tradingview.com
Nuwellis (NUWE) Expands Pediatric Reach With AtriAmp Deal - timothysykes.com
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Nigeria
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Canada
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com India
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com UK
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical - The Manila Times
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingAdvance Decline Line - vinanet.vn
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingOn Balance Volume - dars.gov.et
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotSuperTrend - dars.gov.et
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotVolume Climax - dars.gov.et
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotDouble Bottom - vinanet.vn
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotEarnings Miss Risk - dars.gov.et
Nuwellis Inc (NASDAQ: NUWE) Share Price, NUWE Stock News, NUWE Share Price & Updates - Kalkine
Armistice Capital (NUWE) trims Nuwellis ownership to a 4.99% disclosed stake - Stock Titan
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base Expands - GuruFocus
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ... - Yahoo Finance UK
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis Reports Q2 2026: Revenue $2.0M, Gross Margin 76%, Net Loss $4.8M - TradingView
Nuwellis, Inc. (NASDAQ: NUWE) lifts Q2 2026 revenue and margin but stays unprofitable - Stock Titan
Nuwellis (NASDAQ: NUWE) boosts revenue, flags going concern and Nasdaq risks - Stock Titan
Nuwellis study shows epoprostenol safe for pediatric Aquadex therapy - scanx.trade
Nuwellis Q2 Results: Revenue Up 14% YoY, Gross Margin Expands To 76% - scanx.trade
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com Nigeria
NUWE: Q2 revenue up 14% year-over-year, gross margin at 76%, and net loss reduced to $4.8 million - TradingView
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com
Transcript : Nuwellis, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
Nuwellis Q2 2026 Earnings Call Transcript - Benzinga
Q2 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - marketscreener.com
BRIEF-Nuwellis Q2 EPS USD -26.64 - TradingView
Press Release: Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - Moomoo
NUWE Q2'26 Earnings: EPS estimate is (23.80) USD - TradingView
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis Announces Digital Transformation Program for Aquadex SmartFlow System with Philips Capsule Integration - Quiver Quantitative
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface - The Manila Times
Nuwellis Announces Digital Transformation of the Aquadex Smartflow System with Ehr Connectivity and Enhanced User Interface - marketscreener.com
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Q&A: Building the next generation of cardiorenal care: An interview with Nuwellis - Digital Journal
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):